Literature DB >> 21943802

A framework for the evaluation of "value" and cost-effectiveness in the management of critical limb ischemia.

Neal R Barshes1, Michael Belkin.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21943802     DOI： 10.1016/j.jamcollsurg.2011.07.011

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  9 in total

1.  Cost-effectiveness of revascularization for limb preservation in patients with end-stage renal disease.

Authors:  Neal R Barshes; Panos Kougias; C Keith Ozaki; Philip P Goodney; Michael Belkin
Journal:  J Vasc Surg       Date:  2014-03-20       Impact factor: 4.268

2.  Expansion and angiogenic potential of mesenchymal stem cells from patients with critical limb ischemia.

Authors:  Luke Brewster; Scott Robinson; Ruoya Wang; Sarah Griffiths; Haiyan Li; Alexandra Peister; Ian Copland; Todd McDevitt
Journal:  J Vasc Surg       Date:  2016-02-24       Impact factor: 4.268

3.  Risk assessments and structured care interventions for prevention of foot ulceration in diabetes: development and validation of a prognostic model.

Authors:  Fay Crawford; Francesca M Chappell; James Lewsey; Richard Riley; Neil Hawkins; Donald Nicolson; Robert Heggie; Marie Smith; Margaret Horne; Aparna Amanna; Angela Martin; Saket Gupta; Karen Gray; David Weller; Julie Brittenden; Graham Leese
Journal:  Health Technol Assess       Date:  2020-11       Impact factor: 4.014

4.  Cost-Effectiveness Analysis for the Treatment of Diabetic Foot Ulcer in France: Platelet-Rich Plasma vs Standard of Care.

Authors:  Salvatore Russo; Stefano Landi; Stephane Courric
Journal:  Clinicoecon Outcomes Res       Date:  2022-01-03

5.  An endovascular model of ischemic myopathy from peripheral arterial disease.

Authors:  Chandler A Long; Lucas H Timmins; Panagiotis Koutakis; Traci T Goodchild; David J Lefer; Iraklis I Pipinos; George P Casale; Luke P Brewster
Journal:  J Vasc Surg       Date:  2016-09-29       Impact factor: 4.268

6.  Angiogenic effects of cell therapy within a biomaterial scaffold in a rat hind limb ischemia model.

Authors:  Saeede Amani; Rasoul Shahrooz; Rahim Hobbenaghi; Rahim Mohammadi; Ali Baradar Khoshfetrat; Ali Karimi; Zahra Bakhtiari; Ian M Adcock; Esmaeil Mortaz
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

Review 7.  The system of care for the diabetic foot: objectives, outcomes, and opportunities.

Authors:  Neal R Barshes; Meena Sigireddi; James S Wrobel; Archana Mahankali; Jeffrey M Robbins; Panos Kougias; David G Armstrong
Journal:  Diabet Foot Ankle       Date:  2013-10-10

8.  2D perfusion DSA with an open-source, semi-automated, color-coded software for the quantification of foot perfusion following infrapopliteal angioplasty: a feasibility study.

Authors:  George C Kagadis; Stavros Tsantis; Ilias Gatos; Stavros Spiliopoulos; Konstantinos Katsanos; Dimitris Karnabatidis
Journal:  Eur Radiol Exp       Date:  2020-09-02

Review 9.  Treatment of Peripheral Arterial Occlusive Disease around the Globe: Malta.

Authors:  Anthony Pio Dimech; Samuel Anthony Galea; Kevin Cassar; Matthew Joe Grima
Journal:  J Clin Med       Date:  2021-12-08       Impact factor: 4.241
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.